Skip to content
Homepage
Author:
Kolon TissueGene
Posted Date:
July 20, 2026
Kolon TissueGene Reports Topline ACTiVION-II Phase 3 Clinical Trial Results for TissueGene-C (TG-C) Targeting Osteoarthritis (OA) of the Knee
Kolon TissueGene
July 20, 2026
